Table: Daito -2018/19 group results

Daito Pharmaceutical

12/07/2019 07:00

Jul 12 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2019    May 31, 2018   May 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           41.13           39.88          43.50                 
               (+3.2 pct)      (+5.0 pct)     (+5.7 pct)               
  Operating        4.55            4.16           4.70                 
               (+9.3 pct)      (+8.6 pct)     (+3.4 pct)               
  Recurring        4.64            4.24           4.75                 
               (+9.4 pct)      (+9.4 pct)     (+2.3 pct)               
  Net
  Net              3.51            3.04           3.30                 
               (+15.5 pct)     (+14.5 pct)    (-6.1 pct)               
  EPS          280.73 yen      243.08 yen     263.71 yen               
  Ann Div       38.00 yen       33.00 yen      40.00 yen               
  -Q2 Div       18.00 yen       15.00 yen      20.00 yen               
  -Q4 Div       20.00 yen       18.00 yen      20.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T